Nifty
Sensex
:
:
24666.90
81330.56
88.55 (0.36%)
182.34 (0.22%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524470 | NSE: SYNCOMF

18.45
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  18.13
  •  18.65
  •  18.10
  •  17.99
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1957817
  •  360.83
  •  27.90
  •  10.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,582.96
  • 40.44
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,585.32
  • N/A
  • 4.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.57%
  • 1.02%
  • 45.20%
  • FII
  • DII
  • Others
  • 0.11%
  • 0.00%
  • 3.10%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.27
  • 4.68
  • 6.24

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.08
  • 10.85
  • 8.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.00
  • 10.64
  • 8.55

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.69
  • 53.63
  • 56.00

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.33
  • 1.84
  • 3.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.24
  • 30.69
  • 33.49

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
127.53
65.14
95.78%
102.31
63.84
60.26%
87.25
59.84
45.81%
74.57
60.98
22.29%
Expenses
112.80
57.78
95.22%
90.15
57.43
56.97%
76.80
53.38
43.87%
65.15
55.02
18.41%
EBITDA
14.73
7.36
100.14%
12.16
6.41
89.70%
10.45
6.46
61.76%
9.42
5.96
58.05%
EBIDTM
11.55%
11.30%
11.89%
10.04%
11.98%
10.79%
12.64%
9.77%
Other Income
4.04
4.55
-11.21%
4.15
4.00
3.75%
1.34
1.88
-28.72%
3.10
6.77
-54.21%
Interest
0.20
1.08
-81.48%
0.16
1.08
-85.19%
0.39
1.12
-65.18%
1.19
1.29
-7.75%
Depreciation
1.31
1.45
-9.66%
1.30
0.88
47.73%
1.30
1.10
18.18%
1.30
1.17
11.11%
PBT
17.26
9.36
84.40%
14.85
8.45
75.74%
10.10
6.11
65.30%
10.03
10.28
-2.43%
Tax
4.26
2.36
80.51%
3.74
1.94
92.78%
2.47
1.72
43.60%
2.63
1.81
45.30%
PAT
13.00
7.00
85.71%
11.11
6.51
70.66%
7.63
4.40
73.41%
7.40
8.47
-12.63%
PATM
10.19%
10.75%
10.86%
10.20%
8.75%
7.35%
9.93%
13.89%
EPS
0.14
0.07
100.00%
0.12
0.07
71.43%
0.08
0.05
60.00%
0.08
0.09
-11.11%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
391.66
263.39
224.25
219.66
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
56.79%
17.45%
2.09%
18.85%
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
249.65
117.65
100.65
105.70
102.80
106.54
116.00
101.72
77.54
Gross Profit
142.01
145.74
123.60
113.96
82.03
77.36
57.40
49.57
37.41
GP Margin
36.26%
55.33%
55.12%
51.88%
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
344.90
233.49
204.35
199.63
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
6.13
5.31
4.38
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
2.33%
2.37%
1.99%
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
33.57
24.44
20.73
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
12.75%
10.90%
9.44%
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
41.48
44.08
36.93
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
15.75%
19.66%
16.81%
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
19.38
15.02
14.06
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
7.36%
6.70%
6.40%
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
14.68
14.29
17.32
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
5.57%
6.37%
7.88%
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.61
0.56
0.50
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.23%
0.25%
0.23%
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
46.76
29.90
19.90
20.03
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
11.94%
11.35%
8.87%
9.12%
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
12.63
13.53
14.60
11.99
2.79
2.67
1.98
1.12
1.15
Interest
1.94
4.72
3.40
1.93
0.33
0.14
0.29
0.47
0.52
Depreciation
5.21
4.72
4.54
3.95
3.12
3.00
3.40
2.99
2.83
PBT
52.24
33.98
26.56
26.15
15.89
16.20
16.49
13.93
8.45
Tax
13.10
8.64
6.50
6.39
5.34
5.75
5.88
4.61
2.79
Tax Rate
25.08%
25.44%
24.46%
24.42%
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
39.14
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
39.14
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.99%
9.61%
8.95%
9.01%
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
48.37%
26.11%
1.41%
87.94%
1.64%
6.15%
4.72%
64.66%
 
EPS
0.42
0.27
0.21
0.21
0.11
0.11
0.10
0.10
0.06

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
288.14
256.01
222.22
117.35
108.70
100.22
95.20
87.71
Share Capital
94.00
94.00
86.25
78.07
78.07
78.07
78.07
22.30
Total Reserves
194.14
162.01
130.94
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
10.00
8.66
7.76
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.30
2.69
1.71
0.00
0.00
0.00
0.00
0.00
Current Liabilities
106.52
113.16
78.26
58.84
65.69
36.66
41.62
28.50
Trade Payables
24.14
20.45
13.79
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
6.26
6.91
2.83
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
72.49
83.18
57.79
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
3.63
2.62
3.85
8.27
9.46
9.04
8.11
5.30
Total Liabilities
404.66
377.83
308.24
183.92
180.66
142.50
143.63
124.49
Net Block
72.42
43.40
46.61
55.04
45.85
45.78
50.26
50.47
Gross Block
135.66
101.92
100.68
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
63.25
58.53
54.07
36.94
36.56
34.65
26.93
23.93
Non Current Assets
129.88
196.14
168.44
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
0.00
25.59
6.20
0.25
4.72
0.00
0.00
0.00
Non Current Investment
2.49
1.84
1.93
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
1.01
2.26
2.25
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
6.63
75.73
64.33
0.00
0.00
0.00
0.00
0.00
Current Assets
274.78
181.69
139.80
86.54
91.66
83.59
78.09
61.99
Current Investments
63.70
62.26
41.40
0.00
0.00
0.00
0.00
0.00
Inventories
21.08
21.20
19.51
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
103.30
75.51
67.55
45.99
46.00
31.16
29.42
28.94
Cash & Bank
67.87
8.63
0.39
6.52
5.69
6.77
5.28
3.76
Other Current Assets
18.84
4.46
2.73
10.50
24.51
34.72
33.50
23.22
Short Term Loans & Adv.
10.49
9.63
8.23
13.52
16.10
25.47
27.63
17.28
Net Current Assets
168.26
68.53
61.54
27.70
25.98
46.93
36.47
33.49
Total Assets
404.66
377.83
308.24
183.92
180.65
142.50
143.63
124.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
-5.96
10.53
16.33
13.84
24.07
0.08
6.73
5.78
PBT
33.98
26.56
26.15
15.88
16.10
16.49
13.93
8.45
Adjustment
-3.48
-6.11
-7.16
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
-28.37
-3.26
3.58
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
2.13
17.18
22.58
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-8.08
-6.65
-6.25
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
83.02
-44.95
-27.07
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-8.15
-20.63
-14.65
-5.10
-6.70
-3.25
-2.78
Net Investments
-2.09
-20.80
-12.37
-7.49
-16.99
2.83
-2.57
Others
93.26
-3.52
-0.05
-5.09
0.95
1.16
1.07
Cash from Financing Activity
-14.56
35.00
8.29
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
62.50
0.58
-2.45
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
0.88
0.30
2.75
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
63.38
0.88
0.30
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
3.07
2.72
2.52
1.50
1.39
1.28
1.22
1.12
ROA
6.47%
5.85%
8.04%
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
9.30%
8.48%
11.83%
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
11.05%
9.68%
13.72%
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
2.22
2.21
2.28
2.12
2.28
2.20
2.00
1.55
Receivable days
123.89
116.42
94.33
90.83
75.88
63.71
70.22
91.86
Inventory Days
29.30
33.13
24.52
25.15
25.97
21.92
19.22
19.28
Payable days
69.17
62.08
79.52
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
84.02
87.47
39.33
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.25
0.32
0.27
0.11
0.05
0.06
0.03
0.02
Interest Cover
8.19
8.81
14.58
48.48
119.10
54.58
30.75
17.10

News Update:


  • Syncom Formulations - Quarterly Results
    10th Feb 2025, 16:32 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.